Syndax Pharmaceuticals
SNDX
#6578
Rank
โ‚ฌ0.74 B
Marketcap
8,32ย โ‚ฌ
Share price
6.66%
Change (1 day)
-42.54%
Change (1 year)

EPS for Syndax Pharmaceuticals (SNDX)

EPS in 2026 (TTM): -2,05ย โ‚ฌ

According to Syndax Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -2,15ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -3,00ย โ‚ฌ an increase over its 2024 EPS that were of -3,40ย โ‚ฌ.

EPS history for Syndax Pharmaceuticals from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-2,05ย โ‚ฌ-31.75%
2025-3,00ย โ‚ฌ-11.8%
2024-3,40ย โ‚ฌ26.01%
2023-2,70ย โ‚ฌ20.82%
2022-2,23ย โ‚ฌ-669.77%
20210,39ย โ‚ฌ-122.87%
2020-1,71ย โ‚ฌ1.62%
2019-1,69ย โ‚ฌ-36.43%
2018-2,65ย โ‚ฌ0.69%
2017-2,63ย โ‚ฌ-39.16%
2016-4,33ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,23ย โ‚ฌ-42.80%๐Ÿ‡บ๐Ÿ‡ธ USA